WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Ownership - Who owns Gyre Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gyre Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Songjiang MaPresident2025-05-28558$10.07
$5.62kSell
Songjiang MaPresident2025-05-272,000$10.28
$20.56kSell
Songjiang MaPresident2025-05-23182$10.24
$1.86kSell
Songjiang MaPresident2025-05-222,000$10.97
$21.94kSell
Songjiang MaPresident2025-05-212,000$10.83
$21.66kSell
Songjiang MaPresident2025-05-202,000$11.25
$22.50kSell
Songjiang MaPresident2025-05-192,000$11.11
$22.22kSell
Songjiang MaPresident2025-05-162,000$11.31
$22.62kSell
Songjiang MaPresident2025-05-152,000$10.68
$21.36kSell
Songjiang MaPresident2025-05-1420$11.30
$226.00Sell

1 of 10

GYRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GYRE insiders and whales buy or sell their stock.

GYRE Shareholders

What type of owners hold Gyre Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gni Group Ltd72.96%70,272,408$543.91MInsider
Bvf Partners L P12.11%11,664,575$90.28MInsider
Nea Partners 10 L P8.13%7,827,024$60.58MInsider
Iii Eugene A. Trainor8.13%7,827,024$60.58MInsider
Investment 10 LLC6.41%6,171,669$47.77MInsider
C. Richard Kramlich4.75%4,572,845$35.39MInsider
Peter J. Barris4.75%4,570,845$35.38MInsider
M. James Barrett4.75%4,570,845$35.38MInsider
Scott D. Sandell4.74%4,569,845$35.37MInsider
Charles W. Newhall Iii4.74%4,567,512$35.35MInsider

1 of 3

GYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GYRE2.05%97.95%Net Buying
IOVA16.88%83.12%Net SellingNet Selling
DAWN56.90%43.10%Net SellingNet Selling
MGTX56.42%43.58%Net SellingNet Selling
TBPH51.78%48.22%Net SellingNet Selling
View Top Biotech Stocks

Gyre Therapeutics Stock Ownership FAQ

Who owns Gyre Therapeutics?

Gyre Therapeutics (NASDAQ: GYRE) is owned by 3.54% institutional shareholders, 168.97% Gyre Therapeutics insiders, and 0.00% retail investors. Gni Group Ltd is the largest individual Gyre Therapeutics shareholder, owning 70.27M shares representing 72.96% of the company. Gni Group Ltd's Gyre Therapeutics shares are currently valued at $529.85M.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.